Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Efavirenz Once Daily Over 10 Days Following Drug Intake Cessation in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 29 Oct 2010
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV infections
- Focus Pharmacogenomic; Pharmacokinetics
- 29 Oct 2010 Status changed from recruiting to completed, according to ClinicalTrials.gov.
- 13 Aug 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 13 Aug 2010 Last checked against ClinicalTrials.gov record.